 Maria Amaya
Concepts (93)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Leukemia, Myeloid, Acute | 10 | 2023 | 533 | 1.900 |
Why?
| | Amino Acid Transport System ASC | 1 | 2022 | 10 | 0.780 |
Why?
| | Minor Histocompatibility Antigens | 1 | 2022 | 41 | 0.770 |
Why?
| | Proto-Oncogene Proteins c-myc | 1 | 2022 | 115 | 0.720 |
Why?
| | STAT3 Transcription Factor | 1 | 2022 | 171 | 0.700 |
Why?
| | Bendamustine Hydrochloride | 1 | 2020 | 11 | 0.690 |
Why?
| | Neoplastic Stem Cells | 3 | 2023 | 326 | 0.680 |
Why?
| | Rituximab | 1 | 2020 | 146 | 0.640 |
Why?
| | Lymphoma, B-Cell | 1 | 2020 | 87 | 0.630 |
Why?
| | Immunoconjugates | 1 | 2020 | 87 | 0.630 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 6 | 2023 | 1356 | 0.600 |
Why?
| | Isocitrate Dehydrogenase | 1 | 2018 | 38 | 0.590 |
Why?
| | Azacitidine | 4 | 2023 | 130 | 0.590 |
Why?
| | Signal Transduction | 2 | 2022 | 4439 | 0.570 |
Why?
| | Bridged Bicyclo Compounds, Heterocyclic | 7 | 2023 | 173 | 0.540 |
Why?
| | Mi-2 Nucleosome Remodeling and Deacetylase Complex | 2 | 2013 | 24 | 0.510 |
Why?
| | Molecular Targeted Therapy | 1 | 2018 | 345 | 0.490 |
Why?
| | Antibodies, Monoclonal | 1 | 2020 | 1236 | 0.440 |
Why?
| | gamma-Globins | 1 | 2013 | 1 | 0.430 |
Why?
| | Fetal Hemoglobin | 1 | 2013 | 6 | 0.430 |
Why?
| | Erythroid Cells | 1 | 2013 | 7 | 0.420 |
Why?
| | Gene Silencing | 2 | 2013 | 169 | 0.420 |
Why?
| | Autoantigens | 1 | 2013 | 393 | 0.340 |
Why?
| | Hematopoietic Stem Cells | 1 | 2013 | 337 | 0.340 |
Why?
| | Sulfonamides | 6 | 2023 | 442 | 0.320 |
Why?
| | Antineoplastic Agents | 1 | 2018 | 1872 | 0.290 |
Why?
| | Drug Resistance, Neoplasm | 2 | 2020 | 636 | 0.240 |
Why?
| | Gene Expression Regulation | 1 | 2013 | 2293 | 0.220 |
Why?
| | Oxidative Phosphorylation | 1 | 2022 | 154 | 0.180 |
Why?
| | Lipase | 1 | 2020 | 55 | 0.170 |
Why?
| | Tumor Cells, Cultured | 1 | 2022 | 834 | 0.170 |
Why?
| | Decision Support Systems, Clinical | 1 | 2022 | 176 | 0.170 |
Why?
| | Recurrence | 2 | 2023 | 925 | 0.170 |
Why?
| | Repressor Proteins | 2 | 2013 | 358 | 0.160 |
Why?
| | Cell Survival | 1 | 2022 | 1004 | 0.160 |
Why?
| | Leukemia | 1 | 2020 | 208 | 0.150 |
Why?
| | Triazines | 1 | 2018 | 36 | 0.150 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2023 | 512 | 0.150 |
Why?
| | Aminopyridines | 1 | 2018 | 81 | 0.140 |
Why?
| | Humans | 14 | 2023 | 113531 | 0.120 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2020 | 848 | 0.120 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2020 | 1205 | 0.120 |
Why?
| | Liver | 1 | 2020 | 1630 | 0.100 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2013 | 126 | 0.100 |
Why?
| | Kruppel-Like Transcription Factors | 1 | 2013 | 61 | 0.100 |
Why?
| | Biomarkers, Tumor | 1 | 2018 | 1029 | 0.100 |
Why?
| | RNA, Small Interfering | 1 | 2013 | 528 | 0.090 |
Why?
| | Prognosis | 1 | 2018 | 3318 | 0.090 |
Why?
| | Carrier Proteins | 1 | 2013 | 685 | 0.080 |
Why?
| | Treatment Outcome | 2 | 2022 | 9006 | 0.080 |
Why?
| | Nuclear Proteins | 1 | 2013 | 584 | 0.080 |
Why?
| | Adult | 3 | 2021 | 30245 | 0.070 |
Why?
| | Mice, Transgenic | 1 | 2013 | 1925 | 0.070 |
Why?
| | Mutation | 1 | 2018 | 3313 | 0.070 |
Why?
| | Animals | 4 | 2020 | 31162 | 0.070 |
Why?
| | Epigenesis, Genetic | 1 | 2011 | 515 | 0.070 |
Why?
| | Models, Molecular | 1 | 2011 | 1359 | 0.070 |
Why?
| | Cell Differentiation | 1 | 2013 | 1681 | 0.060 |
Why?
| | Cells, Cultured | 1 | 2013 | 3802 | 0.060 |
Why?
| | DNA-Binding Proteins | 1 | 2011 | 1286 | 0.060 |
Why?
| | Neuraminidase | 1 | 2003 | 22 | 0.050 |
Why?
| | Antigens, CD34 | 1 | 2023 | 87 | 0.050 |
Why?
| | Trypanosoma cruzi | 1 | 2003 | 23 | 0.050 |
Why?
| | Neoplasm, Residual | 1 | 2023 | 105 | 0.050 |
Why?
| | Tyrosine | 1 | 2003 | 203 | 0.050 |
Why?
| | Stem Cell Transplantation | 1 | 2023 | 144 | 0.050 |
Why?
| | Mice | 2 | 2020 | 14679 | 0.050 |
Why?
| | Induction Chemotherapy | 1 | 2021 | 55 | 0.050 |
Why?
| | Glycoproteins | 1 | 2003 | 302 | 0.050 |
Why?
| | Niacinamide | 1 | 2020 | 63 | 0.040 |
Why?
| | Machine Learning | 1 | 2022 | 316 | 0.040 |
Why?
| | Tumor Microenvironment | 1 | 2020 | 428 | 0.040 |
Why?
| | Disease Progression | 1 | 2023 | 2364 | 0.030 |
Why?
| | Stem Cells | 1 | 2020 | 538 | 0.030 |
Why?
| | Retrospective Studies | 2 | 2023 | 12504 | 0.030 |
Why?
| | Cell Proliferation | 1 | 2020 | 2164 | 0.030 |
Why?
| | Aged | 2 | 2021 | 18944 | 0.030 |
Why?
| | Mice, Inbred C57BL | 1 | 2020 | 4617 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2020 | 3470 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2021 | 6296 | 0.020 |
Why?
| | Immunoprecipitation | 1 | 2011 | 150 | 0.020 |
Why?
| | DNA Primers | 1 | 2011 | 496 | 0.020 |
Why?
| | RNA Interference | 1 | 2011 | 426 | 0.020 |
Why?
| | Blotting, Western | 1 | 2011 | 1128 | 0.020 |
Why?
| | DNA Methylation | 1 | 2011 | 493 | 0.020 |
Why?
| | Young Adult | 1 | 2021 | 10400 | 0.020 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 1 | 2003 | 160 | 0.010 |
Why?
| | Catalysis | 1 | 2003 | 288 | 0.010 |
Why?
| | Middle Aged | 1 | 2021 | 26552 | 0.010 |
Why?
| | Enzyme Activation | 1 | 2003 | 752 | 0.010 |
Why?
| | Kinetics | 1 | 2003 | 1528 | 0.010 |
Why?
| | Male | 1 | 2021 | 55112 | 0.010 |
Why?
| | Female | 1 | 2021 | 59115 | 0.010 |
Why?
|
|
Amaya's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|